Antimicrobial Use and Antimicrobial Resistance: A Population Perspective

The need to stem the growing problem of antimicrobial resistance has prompted multiple, sometimes conflicting, calls for changes in the use of antimicrobial agents. One source of disagreement concerns the major mechanisms by which antibiotics select resistant strains. For infections like tuberculosis, in which resistance can emerge in treated hosts through mutation, prevention of antimicrobial resistance in individual hosts is a primary method of preventing the spread of resistant organisms in the community. By contrast, for many other important resistant pathogens, such as penicillin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant Enterococcus faecium resistance is mediated by the acquisition of genes or gene fragments by horizontal transfer; resistance in the treated host is a relatively rare event. For these organisms, indirect, population-level mechanisms of selection account for the increase in the prevalence of resistance. These mechanisms can operate even when treatment has a modest, or even negative, effect on an individual host’s colonization with resistant organisms.

[1]  Y. Carmeli,et al.  Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Tomasz,et al.  High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. , 2001, Pediatrics.

[3]  L. Leibovici,et al.  Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link. , 2001, The Journal of antimicrobial chemotherapy.

[4]  M. Lipsitch,et al.  The rise and fall of antimicrobial resistance. , 2001, Trends in microbiology.

[5]  L H Moulton,et al.  Design of a group-randomized Streptococcus pneumoniae vaccine trial. , 2001, Controlled clinical trials.

[6]  C Peña,et al.  Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. , 2001, JAMA.

[7]  T. Crabtree,et al.  Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit , 2001, Critical care medicine.

[8]  J. Blumer,et al.  Nosocomial acquisition and transmission of antibiotic-resistant Gram-negative organisms in the pediatric intensive care unit , 2001, The Pediatric infectious disease journal.

[9]  D. Livermore,et al.  Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction , 2001, The Lancet.

[10]  M. Lipsitch,et al.  Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Y. Carmeli,et al.  Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  L. Rice,et al.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. , 2000, The New England journal of medicine.

[13]  S. Schrag,et al.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. , 2000, Clinical microbiology reviews.

[14]  Rustom Antia,et al.  Effects of Antiviral Usage on Transmission Dynamics of Herpes Simplex Virus Type 1 and on Antiviral Resistance: Predictions of Mathematical Models , 2000, Antimicrobial Agents and Chemotherapy.

[15]  B. Levin,et al.  Concentration-Dependent Selection of Small Phenotypic Differences in TEM β-Lactamase-Mediated Antibiotic Resistance , 2000, Antimicrobial Agents and Chemotherapy.

[16]  M. Lipsitch,et al.  Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. , 2000, Vaccine.

[17]  P. Farmer,et al.  Redefining MDR-TB transmission 'hot spots'. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  R. J. Hayes,et al.  Design and analysis issues in cluster-randomized trials of interventions against infectious diseases , 2000, Statistical methods in medical research.

[19]  Carl T. Bergstrom,et al.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K Henry,et al.  The Case for More Cautious, Patient-Focused Antiretroviral Therapy , 2000, Annals of Internal Medicine.

[21]  J. John Antibiotic Cycling: Is It Ready for Prime Time? , 2000, Infection Control & Hospital Epidemiology.

[22]  L. Rice,et al.  The Microbial Genetics of Antibiotic Cycling , 2000, Infection Control & Hospital Epidemiology.

[23]  Y. Carmeli,et al.  Control Group Selection Is an Important but Neglected Issue in Studies of Antibiotic Resistance , 2000, Annals of Internal Medicine.

[24]  D. Livermore,et al.  Epidemiology of antibiotic resistance , 2000, Intensive Care Medicine.

[25]  Y. Carmeli,et al.  The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. , 1999, Archives of internal medicine.

[26]  I. Phillips Assessing the evidence that antibiotic growth promoters influence human infections. , 1999, The Journal of hospital infection.

[27]  B. Levin,et al.  The biological cost of antibiotic resistance. , 1999, Current opinion in microbiology.

[28]  Widdowson Ca,et al.  Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. , 1999 .

[29]  Estimation of the direct and indirect effects of vaccination. , 1999, Statistics in medicine.

[30]  J S Koopman,et al.  Individual causal models and population system models in epidemiology. , 1999, American journal of public health.

[31]  R. Anderson,et al.  Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Eliopoulos,et al.  Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. , 1999, Critical care medicine.

[33]  R. Anderson,et al.  Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[34]  Valérie Buthion,et al.  ColoNav: patient navigation for colorectal cancer screening in deprived areas – Study protocol , 1999, BMC Cancer.

[35]  R. Anderson,et al.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Klugman,et al.  Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. , 1999, Seminars in respiratory infections.

[37]  R. Hayes,et al.  Simple sample size calculation for cluster-randomized trials. , 1999, International journal of epidemiology.

[38]  J. Burke Antibiotic resistance--squeezing the balloon? , 1998, JAMA.

[39]  S. Blower,et al.  Predicting and preventing the emergence of antiviral drug resistance in HSV-2 , 1998, Nature Medicine.

[40]  A. Ambergen,et al.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.

[41]  L. Corey,et al.  Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. , 1997, JAMA.

[43]  M Kakehashi,et al.  The transmission dynamics of antibiotic–resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption , 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[44]  M E Halloran,et al.  Study designs for evaluating different efficacy and effectiveness aspects of vaccines. , 1997, American journal of epidemiology.

[45]  S Bonhoeffer,et al.  Evaluating treatment protocols to prevent antibiotic resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Kollef,et al.  Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. , 1997, American journal of respiratory and critical care medicine.

[47]  F. M. Stewart,et al.  The population genetics of antibiotic resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  S. Blower,et al.  Control Strategies for Tuberculosis Epidemics: New Models for Old Problems , 1996, Science.

[49]  J. Boyce,et al.  Treatment and Control of Colonization in the Prevention of Nosocomial Infections , 1996, Infection Control & Hospital Epidemiology.

[50]  I M Longini,et al.  The ecological effects of individual exposures and nonlinear disease dynamics in populations. , 1994, American journal of public health.

[51]  J. Robins,et al.  Invited commentary: ecologic studies--biases, misconceptions, and counterexamples. , 1994, American journal of epidemiology.

[52]  M. Samore,et al.  Clostridium difficile colonization and diarrhea at a tertiary care hospital. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  M E Halloran,et al.  Study designs for dependent happenings. , 1991, Epidemiology.

[54]  M E Halloran,et al.  Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.

[55]  A. Garber,et al.  A discrete-time model of the acquisition of antibiotic-resistant infections in hospitalized patients. , 1989, Biometrics.

[56]  F Lemaire,et al.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. , 1989, Annals of internal medicine.

[57]  J. Mcgowan Minimizing Antimicrobial Resistance in Hospital Bacteria: Can Switching or Cycling Drugs Help? , 1986, Infection Control.

[58]  D. Waaij Antibiotic choice : the importance of colonisation resistance , 1983 .

[59]  S. Levin,et al.  Selection of Intermediate Rates of Increase in Parasite-Host Systems , 1981, The American Naturalist.

[60]  L. Dunkle,et al.  Eradication of epidemic methicillin-gentamicin-resistant staphylococcus aureus in an intensive care nursery. , 1981, The American journal of medicine.

[61]  H. Maibach,et al.  BACTERIAL INTERFERENCE BETWEEN STRAINS OF S. aureus , 1974, Annals of the New York Academy of Sciences.

[62]  S. Erill Letter: Cycloserine and tuberulous meningitis. , 1973, Lancet.

[63]  D. Price,et al.  Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. , 1970, Lancet.

[64]  G. Hardin,et al.  The Tragedy of the Commons , 1968, Green Planet Blues.

[65]  G Hardin,et al.  The tragedy of the commons. The population problem has no technical solution; it requires a fundamental extension in morality. , 1968, Science.